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Neuroendocrine dysfunction, long recognized as a consequence of traumatic brain injury
(TBI), is a major cause of disability that includes physical and psychological involvement
with long-term cognitive, behavioral, and social changes. There is no standard procedure
regarding at what time after trauma the diagnosis should be made. Also there is uncertainty
on deﬁning the best methods for diagnosis and testing and what types of patients should
be selected for screening. Common criteria for evaluating these patients are required on
account of the high prevalence of TBI worldwide and the potential new cases of hypopi-
tuitarism. The aim of this review is to clarify, based on the evidence, when endocrine
assessment should be performed after TBI and which patients should be evaluated. Addi-
tional studies are still needed to know the impact of post-traumatic hypopituitarism and to
assess the impact of hormone replacement in the prognosis.
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Traumatic brain injury (TBI) is a signiﬁcant public health prob-
lem worldwide, with an overall incidence in Western countries of
200–235 cases per 100,000 individuals annually (Tagliaferri et al.,
2006). Approximately 20–40% of TBI episodes involve moderate
to severe traumatic injuries (Frankowski et al., 1985), while 10%
of cases are fatal.
In young adults TBI is considered one of the main causes of
death (Hodgson et al., 2000). Moreover, it is a major cause of dis-
ability that includes physical and psychological involvement with
long-term cognitive, behavioral, and social changes (Salazar et al.,
2000; Khan et al., 2003). Neuroendocrine dysfunction has long
been recognized as a consequence of TBI (Cyran, 1914), partic-
ularly in moderate and severe cases, although the last 10 years
have witnessed a better understanding of the frequency of TBI-
mediated hypopituitarism and its clinical implications, with the
publication of an increasing number of studies (Benvega et al.,
2000; Kelly et al., 2000; Lieberman et al., 2001; Agha et al., 2004;
Bondanelli et al., 2004; Popovic et al., 2004; Aimaretti et al., 2005;
Leal-Cerro et al., 2005; Herrmann et al., 2006; Schneider et al.,
2006; Tanriverdi et al., 2006).
This review is focused in adult patients, but there is also recent
data about TBI-induced hypopituitarism in children and ado-
lescents (Khadr et al., 2010; Moon et al., 2010; Norwood et al.,
2010).
EPIDEMIOLOGY OF HYPOPITUITARISM
Despite the high prevalence of TBI in the general population,brain
injury-related hypopituitarism remains largely under-diagnosed
(Ghigo et al., 2005; Gasco et al., 2010). Brain damage often
presents with signs and symptoms that can easily mask the typi-
cal symptoms of hypopituitarism (Hellawell and Pentland, 2001),
and physicians who care for such patients have little awareness
about the possibility of pituitary deﬁciencies and their impact on
the prognosis, resulting in misdiagnosed cases as an endocrine
assessment is not usually considered.
To date, the prevalence of reported hypopituitarism follow-
ing TBI varies widely among published studies (Kelly et al., 2000;
Lieberman et al., 2001; Popovic et al., 2004; Leal-Cerro et al.,
2005; Tanriverdi et al., 2006). Considering all degrees of hypopi-
tuitarism, from isolated pituitary deﬁciencies to multiple or even
total hypopituitarism, the prevalence ranges from 15 to 90% (Kelly
et al., 2000; Lieberman et al., 2001; Popovic et al., 2004; Leal-Cerro
et al., 2005; Tanriverdi et al., 2006). A meta-analysis including 1015
patients with TBI reported a pooled prevalence of hypopituitarism
of 27.5%. The prevalence of anterior pituitary dysfunction in the
studies included in this meta-analysis ranged from 15 to 68%.
The design and time of pituitary evaluation in these studies were
also variable, ranging from 3months to 7 years following the head
trauma (Schneider et al., 2007).
PATHOPHYSIOLOGY OF HYPOPITUITARISM
The pathophysiology of hypopituitarism following TBI is not
completely understood, and several factors implicated in its
development have been suggested (Dusick et al., 2008).
An important mechanism involved is infarction or ischemia of
the pituitary gland (Malya et al., 2008), an explanation also sup-
ported by the high prevalence of hypopituitarism in patients with
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ischemic stroke (Bondanelli et al., 2010). Vascular damage to the
pituitary can also be caused by several mechanisms:
(1) Traumatic damage to the long hypophyseal portal veins
and subsequent venous infarction are thought to be the
main underlying vascular mechanisms (Daniel et al., 1959;
Kornblum and Fisher, 1969).
(2) Direct traumatic injury to the pituitary gland as demonstrated
by the high prevalence of necrosis or hemorrhage into the
pituitary gland shown in postmortem studies (Crompton,
1971; Salehi et al., 2007).
(3) Multiple secondary insults from hypotension, hypoxia, ane-
mia, and brain swelling, which could also lead to an ischemic
pituitary gland (Wachter et al., 2009).
(4) Another mechanism described as responsible for hypopitu-
itarism due to vascular damage is transection of the pituitary
stalk, which potentially causes hypopituitarism because of
infarction of the pituitary tissue (Daniel et al., 1959; Malya
et al., 2008).
However, recent research has indicated a possible interaction
between autoimmunity and the development of hypopituitarism
following TBI. It has been demonstrated that antipituitary anti-
bodies are present in patients with TBI-induced pituitary dys-
function and persist even 3 years after diagnosis (Tanriverdi et al.,
2008a, 2010a).
WHICH ENDOCRINE DEFICITS ARE THE MOST FREQUENT?
The degree of hypopituitarism, considered as the number of axes
involved, and the prevalence of each pituitary deﬁciency differ in
the various studies published. Some authors have identiﬁed cen-
tral hypogonadism as the most frequent pituitary deﬁciency after
TBI (Benvega et al., 2000; Tanriverdi et al., 2006; Wachter et al.,
2009), although most have reported the GH deﬁciency (GHD) as
the most prevalent (Bondanelli et al., 2004; Popovic et al., 2004;
Aimaretti et al., 2005).
Taking into consideration all data published to date,GHD is the
most common hormone deﬁciency in both severe and moderate
TBI. However, its prevalence varied from 2 to 66%, with 39% of
cases of severe GHD. Prevalence of the other pituitary deﬁcien-
cies was also variable among the studies and ranged from 0 to
60% for secondary adrenal insufﬁciency, 0 to 29% for secondary
hypothyroidism, 0 to 29% for central hypogonadism, and 0 to
48% for abnormal hyperprolactinemia (Benvega et al., 2000; Kelly
et al., 2000; Lieberman et al., 2001; Agha et al., 2004; Bondanelli
et al., 2004; Popovic et al., 2004; Aimaretti et al., 2005; Leal-Cerro
et al., 2005; Herrmann et al., 2006; Schneider et al., 2006; Tan-
riverdi et al., 2006; Kokshoorn et al., 2010). All cases of abnormal
hyperprolactinemia were mild elevations of prolactin and had no
clinical signiﬁcance (Kokshoorn et al., 2010).
This variability could be explained by several factors, includ-
ing a different time interval between TBI and the assessment of
pituitary function (from 24 h to 23 years), the type and severity of
brain injury, and the different methods used to evaluate pituitary
function reserve, such as endocrine tests, assays, and criteria for
the diagnosis of hypopituitarism (Gasco et al., 2010; Kokshoorn
et al., 2010).
The study designmight also inﬂuence the prevalence of hypopi-
tuitarism. Only a few studies have been designed to evaluate the
incidence of hypopituitarism following TBI with speciﬁc criteria
and evaluation at a particular time (Aimaretti et al., 2004, 2005;
Tanriverdi et al., 2006, 2008b) and most of the studies published
are retrospective or cross-sectional (Kelly et al., 2000; Lieberman
et al., 2001; Agha et al., 2004; Bondanelli et al., 2004; Popovic et al.,
2004; Leal-Cerro et al., 2005; Herrmann et al., 2006).
WHEN SHOULD PATIENTS BE SCREENED AFTER TBI?
The time interval between TBI and pituitary hormone assess-
ment is one of the major factors responsible for variations in the
prevalence of hypopituitarism.
The presence of pituitary dysfunction in the early acute phases
(ﬁrst 24 h) or acute phases (up to 2–3weeks) following TBI was
not related to hypopituitarism after 12months (Tanriverdi et al.,
2006, 2008b), as pituitary function was recovered in many patients
(Tanriverdi et al., 2008b). Indeed,pituitary deﬁciencies were found
in 56% of patients when endocrine evaluation was performed
3months after TBI. However, when it was performed 12months
after TBI, pituitary deﬁciencies were only detected in 36% of
cases. GHD was detected in 9 and 10%, at 3 and 12months after
TBI, respectively. Hypogonadism was detected in 32 and 20%,
ACTH deﬁciency in 19 and 9%, and TSH deﬁciency in 8 and 3%,
respectively (Schneider et al., 2006).
Prospective studies have shown the dynamic property of
hypopituitarism in isolated and multiple pituitary deﬁciencies
as well as in the worsening or recovery of pituitary function
(Aimaretti et al., 2005; Tanriverdi et al., 2006, 2008b). Pituitary
recovery 12 years after TBI was also reported (Ruggeri et al., 2010),
possibly due to pituitary revascularization and cellular pituicyte
repopulation (Benvega et al., 2000).
In the early post-traumatic period there are often hormonal
changes thatmimicpituitary dysfunction (Klose et al., 2007a). This
is included in the physiological response to acute and critical ill-
ness, which comprises hormonal changes similar to GHD, central
hypogonadism, and hypothyroidism (Van den et al., 1998). Acute
illness or drugs frequently used in these clinical conditions could
alter the metabolism of the protein binding hormones, resulting
in false deﬁciencies (Agha et al., 2005a).
On the other hand, stress hormones such as cortisol, prolactin,
and vasopressin are increased (Hamrahian et al., 2004; Jochberger
et al., 2006). Consequently, as cortisol should be increased in the
acute phase after TBI, low or low-normal baseline free cortisol
could still be proposed as a potential early marker for the develop-
ment of chronic ACTH deﬁciency in head trauma patients (Klose
et al., 2007a).
This overestimation of hypopituitarism in the acute phase fol-
lowing TBI makes it reasonable to propose the evaluation of
pituitary function at least 1 year after the head trauma and not
at an earlier time point, particularly for hormones that do not
necessarily need to be replaced urgently, such as the gonadal and
somatotropic axes (Lorenzo et al., 2005).
WHICH PATIENTS SHOULD BE SELECTED FOR SCREENING?
Severity of head trauma has been proposed as a predictor of occur-
rence of hypopituitarism and is evaluated by the Glasgow Coma
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Scale (GCS) Score (Teasdale and Jennett, 1974) according to the
consciousness level and ocular and motor movements.
We propose an algorithm (Figure 1) to know who are the
patients that should be screened for pituitary function, based on
evidence.
Many studies (Kelly et al., 2000; Lieberman et al., 2001; Schnei-
der et al., 2006; Tanriverdi et al., 2006) showed that pituitary
deﬁciencies were more frequent in cases of moderate and severe
head trauma (GCS< 13), although patients with severe disability,
as vegetative states, will not beneﬁt from hormonal replacement
and should be excluded from non-vital deﬁciency assessment. On
the other hand, other authors did not ﬁnd any association between
injury severity and prevalence of hypopituitarism (Agha et al.,
2004; Aimaretti et al., 2005; Leal-Cerro et al., 2005; Tanriverdi
et al., 2006). In addition, low-intensity repeated trauma, which
occurs in certain sports, may also result in pituitary deﬁciencies
(Tanriverdi et al., 2010b) probably related to a decrease in pituitary
volume (Tanriverdi et al., 2008c).
Mild TBI, deﬁned as a score between 13 and 15 in the GCS, is
associated with more frequent isolated pituitary deﬁciencies with
a higher proportion of axes recovered after 1 year of follow-up
(Tanriverdi et al., 2006). Conversely, studies published to date
collectively indicate that at 6–2months post-injury, 25–40% of
moderate, and severe TBI patients will develop chronic hypopi-
tuitarism with the somatotropic and gonadotropic axes being
most commonly affected and with a high proportion of persis-
tent deﬁciencies (Schneider et al., 2006; Tanriverdi et al., 2006,
2008b). Indeed, the pooled prevalence of hypopituitarism in cases
of severe, moderate and mild TBI reported by Schneider et al.
(2007) was 35.3, 10.9, and 16.8%, respectively.
There is no cost/beneﬁt indication for global screening of all
cases of mild TBI (Ghigo et al., 2005). However, some situations,
such as the presence of anatomic abnormalities on initial CT (dif-
fuse axonal injury or skull fractures; Schneider et al., 2008), diffuse
brain swelling, hypoxia, hypotension (Kelly et al., 2000), duration
of coma (Benvega et al., 2000), increased intracranial pressure,
longer intubation and hospitalization, and advanced age have been
associated with a worse prognosis and higher incidence of hypopi-
tuitarism (Becker et al., 1977; Bullock et al., 1996; Hellawell and
Pentland, 2001).
WHICH ARE THE MOST APPROPRIATE TESTS FOR
ENDOCRINE ASSESSMENT?
Brain injury-related hypopituitarism is under-diagnosed (Schnei-
der et al., 2007;Gasco et al., 2010),but as the health resources of any
population are limited, screening every patient who undergoes any
head trauma for hypopituitarism should not be recommended.
Accordingly, the most important aspect concerning the diagno-
sis of TBI-associated hypopituitarism is to deﬁne the conditions
related to an increased risk of hypopituitarism, the time interval
from TBI when it is best to evaluate and the endocrine test that
should be performed in such cases.
Endocrine tests and criteria for diagnosis vary among the stud-
ies published. In the case of the GH–IGF-1 axis all patients were
diagnosed with a dynamic test in addition to basal GH and IGF-1
values.However, the dynamic tests used also differ among the stud-
ies and include the insulin tolerance test (Kelly et al., 2000; Klose
et al.,2007a), the glucagon stimulation test (Agha et al.,2004;Bush-
nik et al., 2004; Leal-Cerro et al., 2005), the GHRH–arginine test
(Bondanelli et al., 2004; Aimaretti et al., 2005; Herrmann et al.,
FIGURE 1 | Recommendations for screening in patients with traumatic brain injury (TBI) according to Glasgow Comma Scale (GCS).
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2006), and the GHRH–GHRP6 test (Popovic et al., 2004; Tan-
riverdi et al., 2006). The vagaries of GH provocation test are well
known (Ho, 2007). The optimal diagnostic is the one that identi-
ﬁes those patients that will beneﬁt from treatment with GH and
excludes those that will not (Blair, 2010). The GHRH–GHRP6 test
is rigorous and reliable (Popovic et al., 2000) and is not affected
by known factors that modify GH secretion such as obesity. It
has demonstrated its utility in the diagnosis of GHD after TBI
(Popovic et al., 2004; Tanriverdi et al., 2006) even in a single assay
after a 30-min test (Castro et al., 2007), which is essential from
a practical point of view. A GH peak of under 10μg/l will con-
ﬁrm the diagnosis and above 20μg/l will exclude GHD. In cases
between 10 and 20μg/l another test is needed.
In the case of the adrenal axis, adrenal insufﬁciency can be
diagnosed with a basal level of cortisol when it is extremely low
(under 50 nmol/l, 1.8μg/dl). For the other cases a stimulation
test is needed, and the ACTH stimulation (Lieberman et al., 2001;
Tanriverdi et al., 2006) and insulin tolerance tests (Kelly et al.,
2000; Agha et al., 2005b; Leal-Cerro et al., 2005; Herrmann et al.,
2006) are considered the most appropriate for diagnosis with a
cut-off cortisol level of 550 nmol/l (20μg/dl). In the studies pre-
viously mentioned, ACTH stimulation test was either performed
with 250μg of cosyntropin (Lieberman et al., 2001) and 1μg of
tetracosactrin (Tanriverdi et al., 2006).
For the thyroid, gonadal, and prolactin axes basal levels are
enough for a diagnosis to be made (Aimaretti et al., 2005; Her-
rmann et al., 2006; Tanriverdi et al., 2008b). Low levels of free T4
withnormal or lowTSHallowdiagnosis of central hypothyroidism
to be made, and low levels of testosterone or estrogens with nor-
mal or low FSH and LH are diagnostic of central hypogonadism
(Popovic et al., 2004; Herrmann et al., 2006; Klose and Feldt-
Rasmussen, 2008). Abnormal prolactin is also diagnosed when
basal prolactin levels are not within the normal range (Lieberman
et al., 2001; Popovic et al., 2004; Herrmann et al., 2006; Klose and
Feldt-Rasmussen, 2008).
OUTCOME
Pituitary function affects TBI patient outcome. Hypopituitarism
is thought to contribute to TBI-associated morbidity (Klose and
Feldt-Rasmussen, 2008) and to functional and cognitive ﬁnal
outcome (Bondanelli et al., 2007). In addition, GHD has the
greatest effect on outcome (Kelly et al., 2006; Bondanelli et al.,
2007). Moreover, a clear association has recently emerged between
post-TBI neuroendocrine dysfunction and neurobehavioral and
quality of life impairment (Klose and Feldt-Rasmussen, 2008),
which have increased the interest of doctors in this clinical
condition.
Speciﬁc evaluations of these patients demonstrated an associa-
tion between hypopituitarism and especially GHD and depression
and memory, neuropsychological and cognitive disorders (Kelly
et al., 2006).
Hypopituitarism,whenuntreated,has also been associatedwith
an adverse lipid proﬁle, increased abdominal fat and body mass
index, and deterioration in quality of life (Klose et al., 2007b). It
may also be expected that would signiﬁcantly impede recovery and
rehabilitation following TBI (Blair, 2010).
The Pﬁzer International Metabolic Database (KIMS) reported
a signiﬁcant improvement in quality of life, assessed by the
adult growth hormone deﬁciency assessment (AGHDA) score, in
patients with post-traumatic hypopituitarism and GH treatment
(Kreitschmann-Andermahr et al., 2008). Recent data also suggests
that some of the cognitive impairments observed in patients with
GHD after TBI can improve with GH replacement (High et al.,
2010). Serious and life-threatening adrenal crises due to ACTH
deﬁciency after TBI have signiﬁcantly improved with glucocorti-
coid replacement (Agha et al., 2005b). However, long-term follow-
up studies are still needed to evaluate outcome and the necessity
and beneﬁts of hormone replacement with growth hormone and
gonadal steroids in these patients.
CONCLUSION
The incidence of hypopituitarism following TBI is around 50
patients per 100,000 individuals per year, which results in a high
number of patients affected. Endocrine assessment should be per-
formed 1 year after head injury and only in cases of moderate or
severe TBI, or if mild TBI involves conditions related to a worse
prognosis. However, additional studies are still needed to assess
the impact of hormone replacement in the prognosis.
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